Who We Are
Qualisure Diagnostics Inc. develops molecular tests that enhance cancer care by identifying features that help oncologists personalize treatment.
Understanding which cancers are indolent or aggressive, and which ones are more likely to respond to certain treatments can guide treatment strategy.
Through innovation and collaboration, we help clinicians decide on the right treatment to provide personalized cancer care to every patient.
Introducing Thyroid GuidePx®
Helping guide your papillary thyroid cancer treatment journey!
Understanding Radioactive Iodine Resistance in Thyroid Cancer: Overcoming Treatment Challenges Radioactive iodine (RAI) therapy is a common and effective treatment for thyroid cancer. However, in some cases, patients may not
Radioactive Iodine Therapy: A Precision Weapon against Thyroid Cancer Radioactive iodine (RAI) is a special treatment for thyroid cancer that uses iodine to destroy cancer cells. It is mostly used
Radiofrequency Ablation: An Alternative Approach to Treating Papillary Thyroid Cancer Papillary thyroid cancer (PTC) is the most common type of thyroid cancer, and while surgery remains the primary treatment option,
A clinically useful and biologically informative genomic classifier for papillary thyroid cancer 
Front. Endocrinol., 12 September 2023Sec. Thyroid EndocrinologyVolume 14 – 2023 Clinical management of papillary thyroid cancer depends on estimations of prognosis. Standard care, which relies on prognostication based on clinicopathologic
Anaplastic Thyroid Cancer: A Rare but Aggressive Thyroid Malignancy Thyroid cancer has different types, and one of the most aggressive and least common forms is anaplastic thyroid cancer (ATC). Although